 | • レポートコード：B-MOR-040905 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥569,800 (USD3,850) | ▷ お問い合わせ |
| Team User（7名様用） | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Corporate User | ￥1,221,000 (USD8,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
The Asia-Pacific Brachytherapy is expected to register a CAGR of 5.5% during the forecast period, 2018 to 2023. Japan is expected to dominate the market with highest market share followed and India is expected to be the fastest growing market in this region. Brachytherapy related to the implementation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. It is typically used in high precision treatment of small tumors, mostly found in early stages.
Increased Cancer Patients Population
The rising number of cancer patients have been the major driving factor for this market. Asia alone constitutes around 56% of the world population and contributes to approximately 44% of all cancer cases and 51% of cancer deaths globally. China accounts for largest cancer burden in this region followed by India. With gradual rise in the economic situations in Asia-Pacific region would provide ear access of medications to the patients which drives this market. Other factors such as rise in the number of the minimally invasive surgeries, short treatment time and improved efficiency of these devices provides growth of the market. Further, the growth of medical tourism in this region is having a positive impact on this market such as electronic brachytherapy devices.
Concerns Regarding Side Effects
The brachytherapy market is expected to have restraints in terms of a range of side-effects such as localized bleeding within implant region, urinary incontinence, desquamation, etc. Also this market is expected to face significant competition from external radiation therapy equipment’s market which would hamper the growth of brachytherapy devices.
Japan is Dominating in Asia-Pacific Market
The Asia-Pacific Brachytherapy market is segmented by technique, application, end-user and geography. By geography, it is segmented into China, India, Japan, Australia and Rest of Asia-Pacific.
Japan is expected to dominate the market with highest market share followed and India is expected to be the fastest growing market in this region. Japan is one of the most developed countries in Asia-pacific region and is attributed to the high per-capita healthcare expenditure and the availability of high-end healthcare infrastructure in this country. Apart from that, treatment of cancer is one of the top priorities for the Japanese healthcare system. India is the upcoming country with its rising economic growth has big market of cancer therapy which presents high opportunities of growth in this market as several multinational companies such GE healthcare are providing their high-end treatment.
Major Players: VARIAN MEDICAL SYSTEMS, ELEKTA, BOSTON SCIENTIFC CORPORATION, C.R. BARD inc, COOK MEDICAL INCORPORATED, GE HEALTHCARE, PANACEA MEDICAL TECHNOLOGIES and ARGON MEDICAL DEVICES inc.
Reasons to Purchase this Report
• Current and future Asia-Pacific Brachytherapy Devices market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet in excel
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Number of Cancer Patients
6.1.2 Rising Number of Minimally Invasives Surgeries
6.1.3 Short Treatment Time and Improved Efficiency
6.1.4 Rise of Medical Tourism Industry
6.2 Market Restraints
6.2.1 Concerns Regarding Side Effects Based On Location of Tumor
6.2.2 Introduction of Advanced Radiotherapy
6.3 Opportunities
6.4 Challenges
7. Market Segmentation
7.1 By Technique
7.1.1 High Dose Rate Brachytherapy Devices
7.1.2 Low Dose Rate Brachytherapy Devices
7.1.3 Others
7.2 By Application
7.2.1 Cervical Cancer Brachytherapy Devices
7.2.2 Prostate Cancer Brachytherapy Devices
7.2.3 Breast Cancer Brachytherapy Devices
7.2.4 Skin Cancer Brachytherapy Devices
7.2.5 Others
7.3 By End-User
7.3.1 Hospitals/Clinics
7.3.2 Oncology Treatment Centers
7.3.3 Others
7.4 By Geography
7.4.1 China
7.4.2 Japan
7.4.3 India7.4.4 Australia
7.4.5 Rest of Asia-Pacific
8. Competetive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 Varian Medical Systems
9.2 Elekta
9.3 Boston Scientifc Corporation
9.4 C.R. Bard Inc
9.5 Cook Medical Incorporated
9.6 GE Healthcare
9.7 Panacea Medical Technologies
9.8 Argon Medical Devices Inc
9.9 Others
10. Future of the Market